125 related articles for article (PubMed ID: 4642095)
1. [Effect of butylbiguanide on the metabolism of i.v.administered fructose in patients with liver cirrhosis].
Brodanová M; Brodan V; Kordac V; Marecek Z; Filip J; Slabochová Z
Sb Lek; 1972 Dec; 74(12):366-72. PubMed ID: 4642095
[No Abstract] [Full Text] [Related]
2. Metabolic reflection of fructose infusion in cirrhotic patients and the effect of tolbutamide and butylbiguanide.
Brodanová M; Brodan V; Kordac V; Marecek Z; Slabochová Z; Kuhn E
Acta Hepatogastroenterol (Stuttg); 1973; 20(2):116-24. PubMed ID: 4751153
[No Abstract] [Full Text] [Related]
3. Metabolic reflection of an infusion of fructose, sorbitol and xylitol in healthy subjects and the effect of tolbutamide and butylbiguanide.
Brodan V; Válek J; Slabochová Z; Kuhn E; Brodanová M
Rev Czech Med; 1973; 19(2):89-110. PubMed ID: 4710149
[No Abstract] [Full Text] [Related]
4. Effect of I.V. glucose load on blood glucose, pyruvate and lactate levels in cirrhotics.
el-Ebrashy N; Mashaly M; Shaheen MH; el-Danasoury M
J Egypt Med Assoc; 1975; 58(1-2):27-35. PubMed ID: 1223181
[No Abstract] [Full Text] [Related]
5. [Alcoholic steatosis of the liver. I. Immediate effects of alcohol, fructose and their association on hepatic concentrations of L-alpha-glycerophosphate and nicotinamide-adenine-dinucleotides, in rat].
Hakim J; Cornillot-Clément A; Boivin P; Fauvert R
Pathol Biol (Paris); 1969 Jan; 17(1):59-69. PubMed ID: 4390176
[No Abstract] [Full Text] [Related]
6. [Carbohydrate infusions in internal diseases. A comparative study in metabolically healthy, liver diseased and diabetic patients. VIII. Continuous infusions of low dosage carbohydrate mixtures in patients with liver cirrhosis].
Egberts EH; Müller PH
Infusionsther Klin Ernahr; 1982 Aug; 9(4):166-85. PubMed ID: 6813263
[TBL] [Abstract][Full Text] [Related]
7. [On effect of fructose and glucose on content of carbohydrate metabolites and adenosine phosphates in venous blood of liver in health subjects and patients with liver cirrhosis].
Michel D; Lamprecht W; Göldel L; Zimmermann W; Hagenloh I; Rehling M; Hungbauer E
Hoppe Seylers Z Physiol Chem; 1965; 342(1):140-7. PubMed ID: 5875613
[No Abstract] [Full Text] [Related]
8. The hepatic metabolism of ethanol in patients with cirrhosis of the liver.
Winkler K; Lundquist F; Tygstrup N
Scand J Clin Lab Invest; 1969 Feb; 23(1):59-69. PubMed ID: 5363436
[No Abstract] [Full Text] [Related]
9. [Changes of various blood parameters after an intravenous load of fructose in subjects with liver cirrhosis].
Bianucci G; Pinto S; Morandi GA
Reumatismo; 1976; 28(4):187-97. PubMed ID: 1032565
[No Abstract] [Full Text] [Related]
10. [Carbohydrate infusion in internal diseases. A comparative study of metabolically healthy persons and liver disease and diabetic patients. IV. Infusion of a glucose-fructose mixture (1:1 ratio) over a 48-hour period].
Egberts EH; Weber S; Müller PH; Schmülling R; Prestele H; Horbach L; Malchow H
Infusionsther Klin Ernahr; 1981 Dec; 8(6):308-11. PubMed ID: 7035357
[TBL] [Abstract][Full Text] [Related]
11. [The effect of fructose on glucose formation and oxydation in healthy subjects and patients with liver cirrhosis].
Adlung J; Grazikowske H; Oltmanns D
Infusionsther Klin Ernahr; 1977 Oct; 4(5):266-70. PubMed ID: 562317
[TBL] [Abstract][Full Text] [Related]
12. [Effect of butylbiguanide in retard form on the glucose resorption and lactate-pyruvate concentration in blood].
Schräpler P; Schulz E; Nijssen J; Adlung J
Med Welt; 1977 Mar; 28(9):422-6. PubMed ID: 846382
[No Abstract] [Full Text] [Related]
13. [Carbohydrate infusion in internal diseases. A comparative study in metabolically health, liver diseased and diabetic patients. VII. Infusions of a glucose-fructose-xylitol mixture (relationship 1:2:1) over 48 hours].
Müller PH; Kleber M; Becke F; Egberts EH; Schmülling R; Prestele H; Horbach L; Malchow H
Infusionsther Klin Ernahr; 1982 Jun; 9(3):112-6. PubMed ID: 7049942
[TBL] [Abstract][Full Text] [Related]
14. [Metabolic reflection of fructose infusion in cirrhotic patients and the effect of tolbutamide].
Brodanová M; Brodan V; Kordac V; Marecek Z; Filip J; Slabochová Z; Kuhn E
Sb Lek; 1972 Feb; 74(2):47-56. PubMed ID: 5010500
[No Abstract] [Full Text] [Related]
15. Absorption products of D(-) fructose in man.
Cook GC
Clin Sci; 1969 Dec; 37(3):675-87. PubMed ID: 5363565
[No Abstract] [Full Text] [Related]
16. Absorption and metabolism of D(--) fructose in man.
Cook GC
Am J Clin Nutr; 1971 Nov; 24(11):1302-7. PubMed ID: 5116473
[No Abstract] [Full Text] [Related]
17. [Metabolic consequences of rapid intravenous administration of fructose in patients with cirrhosis and in healthy subjects].
Brodanová M; Filip J; Brodan V
Cas Lek Cesk; 1975 Aug; 114(34-35):1044-9. PubMed ID: 1175192
[No Abstract] [Full Text] [Related]
18. [Effect of intravenous administration of N 1-n-butylbiguanide on carbohydrate and lipid metabolism in diabetics].
Michaelis D; Lippmann HG; Köhler E
Dtsch Gesundheitsw; 1970 May; 25(19):870-4. PubMed ID: 5523783
[No Abstract] [Full Text] [Related]
19. Oral versus intravenous administration of butylbiguanide: effect on oral glucose tolerance in normal humans.
Berger EG; Moehr P
Eur J Clin Invest; 1976 Jun; 6(3):221-8. PubMed ID: 939245
[TBL] [Abstract][Full Text] [Related]
20. [Effect of intravenous fructose load on the P-31 MR spectrum of the cirrhotic liver].
Kachi K; Araki T; Uchiyama G
Nihon Igaku Hoshasen Gakkai Zasshi; 1991 Feb; 51(2):127-32. PubMed ID: 2034518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
